levothyroxine sodium 37.5 MCG Oral Capsule
- RxCUI
- 2630738
- RxNorm name
- levothyroxine sodium 37.5 MCG Oral Capsule
- Display name
- levothyroxine sodium 37.5 MCG Oral Capsule
- Full name
- levothyroxine sodium 37.5 MCG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 2630738 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 37.5 MCG Oral Capsule | SY | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 37.5 MCG Oral Capsule | PSN | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |
| 7a7ade79-0165-4e31-b84e-667416c00c7e | levothyroxine sodium 0.0375 MG Oral Capsule | SCD | 13 | These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000 | 20260325 |